エビデンスに基づくリスク・ベネフィットのコミュニケーション:SDM〈共有意思決定に向けて〉

  • 中山 健夫
    京都大学大学院医学研究科社会健康医学系専攻健康情報学分野

書誌事項

タイトル別名
  • Evidence-based Risk and Benefit Communication for Shared Decision Making
  • Symposium Review エビデンスに基づくリスク・ベネフィットのコミュニケーション : SDM〈共有意思決定に向けて〉
  • Symposium Review エビデンス ニ モトズク リスク ・ ベネフィット ノ コミュニケーション : SDM 〈 キョウユウ イシ ケッテイ ニ ムケテ 〉

この論文をさがす

説明

 Evidence-based medicine (EBM) can be defined as “the integration of the best research evidence with clinical expertise and a patient's unique values and circumstances”. However, even with the best research evidence, many uncertainties can make clinical decisions difficult. As the social requirement of respecting patient values and preferences has been increasingly recognized, shared decision making (SDM) and consensus development between patients and clinicians have attracted attention. SDM is a process by which patients and clinicians make decisions and arrive at a consensus through interactive conversations and communications. During the process of SDM, patients and clinicians share information with each other on the goals they hope to achieve and responsibilities in meeting those goals. From the clinician's standpoint, information regarding the benefits and risks of potential treatment options based on current evidence and professional experience is provided to patients. From the patient's standpoint, information on personal values, preferences, and social roles is provided to clinicians. SDM is a sort of “wisdom” in the context of making autonomous decisions in uncertain, difficult situations through interactions and cooperation between patients and clinicians. Joint development of EBM and SDM will help facilitate patient-clinician relationships and improve the quality of healthcare.<br>

収録刊行物

  • 薬学雑誌

    薬学雑誌 138 (3), 331-334, 2018-03-01

    公益社団法人 日本薬学会

被引用文献 (1)*注記

もっと見る

参考文献 (10)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ